Glimisave MV 3.3 Tablet - Strip of 10

Prescription Required

Compositions : Glimepiride 3mg + Metformin 500mg + Voglibose 0.3mg

₹135.47 (Incl. GST)

MRP :

In stock

Delivery within 2 to 7 Working Days

Manufacture/Marketer: Eris Lifesciences Limited

Glimisave MV 3.3 Tablet is a pharmaceutical product designed to assist in the management of diabetes mellitus, particularly in patients with type 2 diabetes. This medication combines multiple active ingredients that work synergistically to help control blood sugar levels effectively. The primary components of Glimisave MV 3.3 Tablet include Metformin, Glimepiride, and Voglibose, each contributing to its therapeutic efficacy. Metformin is known for its ability to decrease hepatic glucose production and improve insulin sensitivity, while Glimepiride stimulates insulin secretion from the pancreas. Voglibose, an alpha-glucosidase inhibitor, slows down carbohydrate absorption in the intestines, further aiding in blood sugar control. Together, these ingredients make Glimisave MV 3.3 Tablet a comprehensive option for individuals struggling to maintain optimal glucose levels. The formulation is designed to be taken orally, providing a convenient option for daily management of diabetes. It is essential for patients to use Glimisave MV 3.3 Tablet as part of a broader diabetes management plan that includes dietary modifications and regular physical activity. The product is typically prescribed when lifestyle changes alone are insufficient to achieve desired glycemic control. By addressing multiple pathways involved in glucose metabolism, Glimisave MV 3.3 Tablet offers a multifaceted approach to diabetes management, making it a valuable addition to the therapeutic arsenal against this chronic condition.

Uses & Benefits

  • Helps in controlling blood sugar levels in patients with type 2 diabetes.
  • Reduces the risk of diabetes-related complications.
  • Improves insulin sensitivity and decreases hepatic glucose production.
  • Stimulates insulin secretion from the pancreas.
  • Slows down carbohydrate absorption in the intestines.
  • Can be used alongside dietary changes and exercise for better glycemic control.
  • May help in weight management as part of a comprehensive diabetes care plan.
  • Suitable for patients who have not achieved adequate control with diet and exercise alone.
How Glimisave MV 3.3 Tablet works

  • Metformin reduces glucose production in the liver and enhances insulin sensitivity.
  • Glimepiride stimulates the pancreas to release more insulin in response to meals.
  • Voglibose inhibits enzymes that break down carbohydrates, leading to slower glucose absorption.
  • The combination of these actions helps maintain stable blood sugar levels throughout the day.
How to use Glimisave MV 3.3 Tablet

  • Take Glimisave MV 3.3 Tablet orally with water.
  • Dosage is typically prescribed by a healthcare professional based on individual needs.
  • Commonly recommended dosage is one tablet taken once daily.
  • It is advisable to take the tablet with meals to minimize gastrointestinal side effects.
  • Do not exceed the prescribed dosage without consulting your doctor.
  • Continue taking the medication even if you feel well; do not stop without medical advice.
  • Regular monitoring of blood sugar levels is recommended while using this medication.
Lifestyle Advice

  • Maintain a balanced diet rich in whole grains, fruits, and vegetables.
  • Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
  • Monitor blood sugar levels regularly to understand how food and activity affect your glucose levels.
  • Avoid excessive consumption of sugary foods and beverages.
  • Stay hydrated by drinking plenty of water throughout the day.
  • Consider working with a dietitian for personalized meal planning.

Side Effects

  • Common side effects include nausea, vomiting, diarrhea, and abdominal pain.
  • Some patients may experience dizziness or headache.
  • Serious side effects can include hypoglycemia (low blood sugar), which may present as sweating, shaking, confusion, or fainting.
  • If you experience symptoms of lactic acidosis such as unusual muscle pain, difficulty breathing, or feeling cold, seek immediate medical attention.
  • Allergic reactions may occur; watch for symptoms like rash, itching, or swelling.

Precautions and Warnings

  • Do not use Glimisave MV 3.3 Tablet if you have a known allergy to any of its components.
  • Caution is advised for patients with kidney or liver disease; dosage adjustments may be necessary.
  • Pregnant or breastfeeding women should consult their healthcare provider before use.
  • Avoid driving or operating heavy machinery if you experience dizziness or low blood sugar symptoms.
  • Inform your doctor about any other medications you are taking to avoid potential interactions.
1. Is Glimisave MV 3.3 Tablet safe for everyone?
Glimisave MV 3.3 Tablet may not be suitable for individuals with certain medical conditions or those who are pregnant or breastfeeding. Always consult your healthcare provider before starting any new medication.

2. What should I do if I miss a dose of Glimisave MV 3.3 Tablet?
If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double up on doses.

3. Can I drink alcohol while taking Glimisave MV 3.3 Tablet?
Alcohol can affect blood sugar levels and may increase the risk of side effects. It is advisable to limit alcohol consumption while taking this medication.

4. How should I store Glimisave MV 3.3 Tablet?
Store Glimisave MV 3.3 Tablet at room temperature, away from moisture and heat. Keep it out of reach of children.

5. What are the common side effects of Glimisave MV 3.3 Tablet?
Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort. If side effects persist or worsen, consult your healthcare provider.

6. Can Glimisave MV 3.3 Tablet interact with other medications?
Yes, Glimisave MV 3.3 Tablet may interact with other medications. Always inform your doctor about all medications you are taking.

7. Who should avoid using Glimisave MV 3.3 Tablet?
Individuals with severe kidney or liver impairment should avoid using this medication unless directed by a healthcare professional.

Directions for Use

Use only as prescribed by your physician.

Storage and Disposal

Please refer to the product label for storage information.
SKU 125028
Country of Manufacture India
Manufacturer Address Eris Lifesciences Limited
Return/Buy Back policy Non-returnable
Prescription Required Yes
Storage Please refer to the product label for storage information.
Seller Kogland Commerce Pvt Ltd (TN)

Door Step Delivery

Quick and Secure

No Hidden Charges

Pay only what's shown

18K Pincodes Served

With Trust & Reliability

Customer Reviews

No reviews yet

Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.

Write Your Own Review

Only registered users can write reviews. Please Sign in or create an account

Please wait…

Share Your Requirements With Us

Please fill out the form below. We'll get back to you. Thank you for your patience.